81607-019Level 3
liraglutide (liraglutide)
**Product type:** Human Prescription Drug
**Active ingredient:** LIRAGLUTIDE
**Strength:** 6 mg/mL
**Dosage form:** Injection, Solution
**Route:** Subcutaneous
**Labeler:** Orbicular Pharmaceutical Technologies Private Limited
**Marketing category:** ANDA (ANDA217234)
**Pharmacologic class:** GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/81607-019Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.